Tuesday, August 3, 2021
Home Breaking News GBT Seeking to Develop New EDA Technology to Achieve Improved IC DFM...

GBT Seeking to Develop New EDA Technology to Achieve Improved IC DFM (Design for Manufacturing)

SAN DIEGO, March 18, 2021 (GLOBE NEWSWIRE) — GBT Technologies Inc. ( OTC PINK: GTCH ) (“GBT” or the “Company”), is seeking to develop a new EDA (Electronic Design Automation) technology to achieve IC’s better DFM (Design For Manufacturing) analysis.

As Integrated Circuits (IC) technology advances, manufacturing and complexity are constantly growing. Microchips are being scaled down to meet the never-ending increasing demand for more functionalities, lower power consumption, higher performance and lower cost, creating major design and manufacturing challenges. Especially with deep nanometer chips, manufacturing is facing massive challenges in terms of silicon manufacturability, and yield efficiency. Power-Performance-Area (PPA), performance and design power constraints are making turnaround schedules for manufacturers difficult to achieve. GBT commenced a research and development efforts to introduce an analytical system and method to address yield considerations to help produce IC designs with the goal of providing more yield efficient. The EDA R&D efforts will be concentrating on DFM rules analysis, physical layout geometrical rules (DRC) and nanometer silicon modeling. The planned solution will be a real-time, interactive guiding system with the goal of enabling DFM advice/auto-correction early during the microchip’s design stage. GBT already started to address a key dependency between manufacturing and IC design; the Design Rule Check (DRC) aspect. IC DRC rules are geometrical design constraints, imposed by the manufacturing process. These constraints are enforced due to manufacturing process limitations and typically required long design time to achieve compliance. The new approach will target to embed DFM manufacturing rules along with geometrical rules check (DRC) to advise designers with the goal of making their IC design more compatible for manufacturing. The goal is to increase silicon yield, obeying to power and performance constraints, through early adherence of DFM rules, rather than complying only with DRC rules.

“The quest to comply with DFM rules has become a true challenge, especially as we dive into advanced nanometer nodes. As part of our ongoing EDA R&D efforts we identified IC verification domains that are a bottleneck for design schedules and time to market factors. We already addressed major time-consuming topics in this area which are geometrical rules (DRC) and reliability verification (RV). As we expand our EDA physical design solutions, we plan to address DFM (Design for Manufacturing) recommended rules, combining them with DRC rules to enable robust analytics to shortened advanced nodes ICs design while obeying power constraints and performance to increase the silicon yield. Ultimately all physical aspects of a microchip design affect each other and have mutual implications. Therefore, our approach is to address them together within one integrated analysis, including their dependencies. We believe that this is the best way to deliver a comprehensive, effective DFM aware solution. By taking into effect the IC’s design area, the DRC and the DFM recommended rules we aim to significantly improve the yield, especially for deep nanometer nodes like 5nm and below. With this approach, we target to implement machine learning IC physical layout statistical modeling for critical areas analysis and other manufacturing related topics. We truly believe that only by addressing these topics as one homogenous EDA solution, an effective signoff design for DFM can be achieved” stated Danny Rittman, the Company’s CTO.

There is no guarantee that the Company will be successful in researching, developing or implementing this system. In order to successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched, developed and granted regulatory approval, the Company would need to enter into a strategic relationship with a third party that has experience in manufacturing, selling and distributing this product. There is no guarantee that the Company will be successful in any or all of these critical steps.

About Us

GBT Technologies, Inc. (OTC PINK: GTCH) (“GBT”) ( http://gbtti.com ) is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT’s mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT’s goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS). GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT’s vision is to produce this system as a low cost, secure, private-mesh-network between all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.

Forward-Looking Statements

Certain statements contained in this press release may constitute “forward-looking statements”. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements because of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website ( http://www.sec.gov ). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company’s ability to raise capital on acceptable terms, if at all, the Company’s successful development of its products and the integration into its existing products and the commercial acceptance of the Company’s products. The forward-looking statements included in this press release represent the Company’s views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of the press release.

Dr. Danny Rittman, CTO


This article is for the purposes of solicitation subscriptions for this website. This website expects to generate new advertisement revenue resulting from the distribution of this article. The amount of which is unknown at this time. This website or it’s authors do not own any shares of GBT Technologies Inc (GTCH) and does not buy, sell, or trade any shares of (GTCH). This article does not provide a professional analysis of a (GTCH) financial position. (GTCH) financial position and all other information regarding the featured Company should be verified directly with (GTCH). Please read our full disclaimer for more detailed information.

Most Popular

NxGen Brands, Inc. Enters Into A Definitive Agreement To Acquire 100% Of Healthcard LLC; Acquisition Brings Company Ownership Of Proprietary Patent Pending Patient Centric...

NxGen Brands, Inc. Enters Into A Definitive Agreement To Acquire 100% Of Healthcard LLC; Acquisition Brings Company Ownership Of Proprietary Patent Pending Patient...

NxGen Brands, Signs Letter of Intent (LOI) to Acquire HealthCard, Technology Company That Has Patent Pending Registration for Patient Centric Universal Health Recording &...

NxGen Brands, Signs Letter of Intent (LOI) to Acquire HealthCard, Technology Company That Has Patent Pending Registration for Patient Centric Universal Health Recording...

Nutra Pharma Announces that Diverse Health Services has Added Nyloxin to Their Product Offerings

Diverse Health Services, an industry leader in Chiropractic care and Alternative Medicine, announced the addition of the Nyloxin(R) line of pain relief...

Nutra Pharma Announces Private Label Expansion of their Over-The-Counter Pain Relievers

Nutra Pharma is announcing the first private label agreement in expansion of their line of over-the-counter pain relievers and anti-inflammatory drugs


Subscribe to our Stock News Alerts

Mobile is not required however if you want the fastest
delivery be sure to add your mobile.

Subscribe to our News Alerts